Bryan Lizza

450 total citations
25 papers, 301 citations indexed

About

Bryan Lizza is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bryan Lizza has authored 25 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Critical Care and Intensive Care Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bryan Lizza's work include Sepsis Diagnosis and Treatment (6 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Pneumonia and Respiratory Infections (4 papers). Bryan Lizza is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Pneumonia and Respiratory Infections (4 papers). Bryan Lizza collaborates with scholars based in United States, Philippines and Italy. Bryan Lizza's co-authors include Matthew B. Maas, Andrew M. Naidech, Eric M. Liotta, Scott T. Micek, Kevin D. Betthauser, Kathryn J. Reid, Phyllis C. Zee, Marin H. Kollef, Brandon Francis and Rajbeer Singh Sangha and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Bryan Lizza

24 papers receiving 292 citations

Peers

Countries citing papers authored by Bryan Lizza

Since Specialization

Citations

This map shows the geographic impact of Bryan Lizza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Lizza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Lizza more than expected).

Fields of papers citing papers by Bryan Lizza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Lizza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Lizza. The network helps show where Bryan Lizza may publish in the future.

Co-authorship network of co-authors of Bryan Lizza

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Lizza. A scholar is included among the top collaborators of Bryan Lizza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Lizza. Bryan Lizza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning to predict vasopressin responsiveness in patients with septic shock 2022 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Kevin D. Betthauser, (unknown), (unknown), Bryan Lizza, Scott T. Micek, Patrick G. Lyons	12
2	Antibiotic Optimization in the Intensive Care Unit 2022 ·Seminars in Respiratory and Critical Care Medicine ·Bryan Lizza, (unknown), Scott T. Micek	5
3	Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study 2021 ·Hospital Pharmacy ·Christopher A. Jones, Kevin D. Betthauser, Bryan Lizza, (unknown), Scott T. Micek, Marin H. Kollef	2
4	Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort Study 2021 ·Clinical Therapeutics ·Kevin D. Betthauser, (unknown), Paul Juang, Bryan Lizza, Scott T. Micek, Marin H. Kollef	0
5	How to use new antibiotics in the therapy of ventilator-associated pneumonia 2021 ·Current Opinion in Infectious Diseases ·(unknown), Bryan Lizza, Jason P. Burnham, Hitoshi Honda, Marin H. Kollef	1
6	235: PATIENT MEMORIES FROM THE INTENSIVE CARE UNIT FOLLOWING COVID-19 2021 ·Critical Care Medicine ·Donna Prentice, Beth Taylor, Heidi Tymkew, (unknown), (unknown), (unknown), Kevin D. Betthauser, Bryan Lizza, Emily Wilson, Sarah Smith, Christopher Palmer	2
7	The Feasibility and Validity of Objective and Patient-Reported Measurements of Cognition During Early Critical Illness Recovery 2020 ·Neurocritical Care ·Matthew B. Maas, Bryan Lizza, Minjee Kim, (unknown), Eric M. Liotta, Kathryn J. Reid, Phyllis C. Zee, James W. Griffith	2
8	Circadian Gene Expression Rhythms During Critical Illness 2020 ·Critical Care Medicine ·Matthew B. Maas, Marta Iwanaszko, Bryan Lizza, Kathryn J. Reid, Rosemary Braun, Phyllis C. Zee	25
9	Factors Disrupting Melatonin Secretion Rhythms During Critical Illness 2020 ·Critical Care Medicine ·Matthew B. Maas, Bryan Lizza, Sabra M. Abbott, Eric M. Liotta, (unknown), (unknown), Andrew M. Naidech, Kathryn J. Reid, Phyllis C. Zee	28
10	Stress-Induced Behavioral Quiescence and Abnormal Rest-Activity Rhythms During Critical Illness 2020 ·Critical Care Medicine ·Matthew B. Maas, Bryan Lizza, Minjee Kim, Sabra M. Abbott, (unknown), Kathryn J. Reid, Phyllis C. Zee	18
11	Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL 2019 ·CHEST Journal ·(unknown), (unknown), Chiagozie I. Pickens, Bryan Lizza, Helen K. Donnelly, Michael Malczynski, Chao Qi, Richard G. Wunderink	41
12	Impact of Multiple Daily Clinical Pharmacist-Enforced Assessments on Time in Target Sedation Range 2017 ·Journal of Pharmacy Practice ·Bryan Lizza, (unknown), (unknown), Cyrus Cooper, Elizabeth J. Short, Matthew B. Maas, Andrew M. Naidech, Richard G. Wunderink	7
13	Pharmacist Education at Discharge Correlates with Reduced 30-Day Readmissions in Heart Failure Patients 2017 ·Journal of Cardiac Failure ·(unknown), (unknown), Bryan Lizza, Clyde W. Yancy, R. Kannan Mutharasan	1
14	Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment 2017 ·Cerebrovascular Diseases ·Matthew B. Maas, Brandon Francis, Rajbeer Singh Sangha, Bryan Lizza, Eric M. Liotta, Andrew M. Naidech	33
15	Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy 2017 ·Critical Care Medicine ·Eric M. Liotta, (unknown), Bryan Lizza, Laura J. Rasmussen‐Torvik, Minjee Kim, Brandon Francis, Rajbeer Singh Sangha, Timothy Carroll, Daniel Ganger, Daniela P. Ladner, Andrew M. Naidech, James Paparello, Shyam Prabhakaran, Farzaneh A. Sorond, Matthew B. Maas	21
16	Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections 2016 ·Journal of Infection and Chemotherapy ·Bryan Lizza, Nathaniel J. Rhodes, John S. Esterly, (unknown), (unknown), Marc H. Scheetz	9
17	23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker 2015 ·Critical Care Medicine ·Eric M. Liotta, Bryan Lizza, (unknown), James Guth, (unknown), Timothy Carroll, Brandon Francis, Daniel Ganger, Daniela P. Ladner, Matthew B. Maas, Andrew M. Naidech	13
18	Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse 2015 ·Antimicrobial Agents and Chemotherapy ·Nathaniel J. Rhodes, J. Nicholas O’Donnell, Bryan Lizza, Milena M. McLaughlin, John S. Esterly, Marc H. Scheetz	14
19	Extended-Infusion Eptifibatide to Prevent Stent Thrombosis in a Patient Undergoing Orthopedic Surgery 2011 ·Annals of Pharmacotherapy ·Bryan Lizza, (unknown)	2
20	Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients 1995 ·Nephrology Dialysis Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bryan Lizza, Alessandra Perna	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact